Friday, 4 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 6, 2026

Atlassian targets 20%+ annual revenue growth through FY27 amid accelerating AI adoption and record enterprise expansion

View original at seekingalpha.com
Atlassian targets 20%+ annual revenue growth through FY27 amid accelerating AI adoption and record enterprise expansion Earnings Call Insights: Atlassian Corporation (TEAM) Q2 2026 MANAGEMENT VIEW * CEO Michael Cannon-Brookes opened the call stating "we closed out Q2 with very strong enterprise sales execution and incr…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Data center segment expected to be down meaningfully next year

    80% confidence
  • Gross margin improvements continuing for third or fourth consecutive quarter while delivering 5 million Rovo seats

    80% confidence
  • Current pricing is delivering and customers' preferred payment method is still seat-based model

    80% confidence
  • No change to midterm outlook of 20%+ compounded annual revenue growth through FY27 and 25%+ non-GAAP operating margin in FY27

    80% confidence
  • Cloud migrations contributed mid-to-high single-digit impact to cloud revenue growth rates in Q2

    80% confidence
  • There is a ton of fear in the market right now on software

    80% confidence
  • Rovo surpassed 5 million monthly active users and AI is transforming how work gets done

    80% confidence
  • More than 1,000 customers have upgraded to Teamwork Collection in less than 3 quarters, purchasing over 1 million seats

    80% confidence
  • Migrations expected to drive mid-to-high single-digit contribution to cloud revenue growth for full FY26

    80% confidence
  • Atlassian closed a record number of deals greater than $1 million ACV in Q2, nearly doubling year-over-year

    80% confidence
  • Customer conversations have changed a lot over the last year and customers are looking for strategic partners to help them through AI

    80% confidence
  • Atlassian has confidence in long-term cloud guide and expects to tap into large market opportunities through enterprise AI and system of work strategies

    80% confidence
  • Anthropic is a great partner of Atlassian, highlighting integration not competition

    80% confidence
  • Service collection is doing very well and is definitely Atlassian's fastest-growing product at significant scale

    80% confidence
  • Companies using AI codegen tools create 5% more tasks with Jira, have 5% higher monthly active users and expand Jira seats 5% faster

    80% confidence
  • Atlassian closed out Q2 with very strong enterprise sales execution and surpassed $6 billion in annual run rate revenue

    80% confidence
  • Seat expansion is broad-based across both tech and non-tech users and remains stable

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com
Atlassian targets 20%+ annual revenue growth through FY27 amid accelerating AI adoption and record enterprise expansion — Source | Via News | ViaNews EU